HTHaoxian Tang

Haoxian Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haoxian Tang has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3

    by Xiaojing Chen, Haoxian Tang, Zhuokai Xu, Xueying Chen, Cuihong Tian, Nan Luo, Jingtao Huang, Hanyuan Lin, Xuan Zhang, Qinglong Yang, et al.

    Growth differentiation factor 15 (GDF-15) is a circulating biomarker reflecting oxidative stress, inflammation, and cellular aging. However, its role in disease risk assessment amongst individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3 remains unclear. This study included 29,697 UK Biobank participants with CKM stages 0-3 defined in accordance with the American Heart Association criteria. Associations of GDF-15 with metabolic, inflammatory and liver fibrosis markers and CKM stage were examined using linear or multinomial logistic regression models. Fine-Gray competing risk regression models were used to evaluate associations with incident atherosclerotic cardiovascular disease (ASCVD), metabolic dysfunction-associated steatotic liver disease (MASLD) and their comorbidity (coexistence of both conditions). Bidirectional disease transitions were assessed using a multi-state Markov model. The relative importance of GDF-15 was evaluated using SHapley Additive exPlanations (SHAP) and likelihood ratio (LR) statistics. Improvements in risk prediction models were assessed using time-dependent area under the receiver operating characteristic curve, Brier score, integrated discrimination improvement and continuous net reclassification improvement. Amongst 29,697 participants (mean age of 56.16 years; 57.32% female), 2,786 developed ASCVD and 456 developed MASLD during follow-up. Higher GDF-15 levels were associated with poorer CKM health and showed the strongest associations with renal function markers, followed by insulin resistance indices. Each 1-unit increase in GDF-15 (normalised protein expression, log2 scale) was associated with increased risks of ASCVD (HR = 1.25, 95%CI 1.15-1.36, P = 1.35 × 10-7), MASLD (HR = 1.62, 95%CI 1.41-1.86, P = 2.06 × 10-11) and their comorbidity (HR = 1.62, 95%CI 1.32-2.18, P = 4.36 × 10-7) after multivariable adjustment for age, sex, smoking status, body mass index, diabetes mellitus, glycated haemoglobin, systolic blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, creatinine, estimated glomerular filtration rate, urinary albumin-to-creatinine ratio, cystatin C, Townsend deprivation index, physical activity, and CKM stage. These associations remained consistent across subgroup analyses. Multi-state analyses indicated that GDF-15 predicted bidirectional progression between ASCVD and MASLD, with 10-year cumulative incidences of ASCVD and MASLD reaching 15.75% and 2.03%, respectively, among individuals in the top 10% of GDF-15 levels, and further increasing to 20.05% and 2.32% in those in the top 5%. SHAP and LR analyses showed that GDF-15 had high relative importance in predicting ASCVD and MASLD. Incorporating GDF-15 into established risk scores (PREVENT, SCORE2, FLI, FIB-4 and ARPI) showed modest improvements in risk discrimination, reclassification, and prediction error, particularly for ASCVD. In several settings, GDF-15 outperformed established biomarkers, including insulin resistance, systemic inflammation, apolipoprotein A/B, lipoprotein(a), cardiac troponin I, and N-terminal prohormone of brain natriuretic peptide. GDF-15 may serve as a promising biomarker for cardiovascular-kidney-liver-metabolic syndrome risk stratification and management.


  • Open Access

    Food ultra-processing, plant-origin foods, and risk of benign prostatic hyperplasia: evidence from the UK Biobank cohort

    by Qinglong Yang, Haolin Chen, Nan Luo, Hanyuan Lin, Haoxian Tang, Zexuan Liu, Jingtao Huang, Xuan Zhang, Gaoming Hou, Wenqiang Liao, et al.

    Benign prostatic hyperplasia (BPH) frequently affects men in middle and later life; however, the potential influence of ultra-processed food (UPF) consumpt


  • Open Access

    Global Disease Burden of Traumatic Joint Dislocation from 1990 to 2021 and its prediction to 2045

    by Jingtao Huang, Haoxian Tang, Jiayou Chen, Rongji Liang, Shicheng Jia, Zilu Jiao, Lin Li, Xuan Zhang, Jingyue Su, Zhenhan Deng, et al.

    Background Traumatic joint dislocations of the hip, knee, and shoulder (DOH, DOK, and DOS) significantly impact global healthcare. This study assesses the global burden of joint dislocations using the Global Burden of Disease (GBD) 2021 database, focusing on their association with the socio-demographic index (SDI). Methods Data from the GBD 2021 are analyzed to determine the age-standardized rates (ASR) of incidence, prevalence, and years lived with disability (YLDs) for dislocations. We integrate the SDI with the concentration index, assessing disparities in the burden of these joint dislocations. Frontier analysis is performed to identify potential improvement areas and disparities among countries by development status. The age-period-cohort (APC) model projects the disease burden to 2045, with a focus on age and gender distributions and primary causes. Results From 1990 to 2021, the incidence, prevalence, and YLDs of DOH/DOK/DOS all increase, while ASRs decline, suggesting a deceleration in growth. YLDs of DOH, DOK, and DOS rise by 57.21%, 28.38%, and 15.48%, respectively. Men exhibit a higher burden, yet women show a steeper rise. Significant geographical variation exists, with lower SDI countries facing higher burdens. Falls and road injuries remain the main contributors to the burden, and lower-development countries demonstrate potential for reduction. Temporal trends vary by age, sex, and SDI, with projections indicating continued disparities to 2045. Conclusions Traumatic joint dislocations show marked heterogeneity in age, sex, and SDI, with the most significant differences in low-income regions. Research should prioritize policy development and targeted prevention and treatment strategies for groups at high-risk for joint dislocation to effectively mitigate the disease burden.

  • Open Access

    Sugar rationing during the first 1000 days of life and lifelong risk of heart failure

    by Haoxian Tang, Xuan Zhang, Jingtao Huang, Xiaojing Chen, Jianan Hong, Hanyuan Lin, Cuihong Tian, Luo Nan, Mengyue Lin, Qinglong Yang, et al.

    Elevated sugar intake has been linked to poor cardiovascular health, but the effects of early-life sugar restriction on the lifelong risk of heart failure remain unclear. Using the end of sugar rationing in the United Kingdom in 1953 as a natural experiment, we classify participants in the UK Biobank by birth timing to define early-life exposure to sugar rationing. Here we show that individuals exposed to early-life sugar rationing exhibit an approximately 14% lower risk of heart failure and develop the condition about 2.6 years later than those unexposed. Longer exposure is associated with stronger effects, and population-level estimates suggest that around 4–5% of heart failure cases may be attributable to the absence of early-life sugar restriction. Genetic susceptibility does not modify these associations but acts additively. These findings underscore the long-term importance of early-life sugar exposure for heart failure, and further studies are warranted.


  • Systemic Immune‐Inflammation Index and Neutrophil‐To‐Lymphocyte Ratio: U‐Shaped Association With Overactive Bladder

    by Qinglong Yang, Haolin Chen, Hanyuan Lin, Haoxian Tang, Nan Luo, Xuan Zhang, Jingtao Huang, Xuxia Sui, Qingtao Yang

    Objectives: This study aims to examine the association of systemic immune‐inflammation index (SII) and neutrophil‐to‐lymphocyte ratio (NLR) with the prevalence of overactive bladder (OAB).Methods: This cross‐sectional study analyzed data from 22,343 participants (≥ 20 years) in the National Health and Nutrition Examination Survey (2005–2018). We applied weighted multivariate logistic regression, restricted cubic spline (RCS) regression, subgroup, and sensitivity analyses to assess the associations between SII, NLR, and OAB.Results: RCS analysis revealed U‐shaped relationships with inflection points at 6.13 for ln(SII) and 0.65 for ln(NLR). In the fully adjusted model, ln(SII) ≤ 6.13 showed a negative correlation with OAB (OR = 0.83; 95% CI: 0.70–0.99), while ln(SII) > 6.13 was positively correlated (OR = 1.32; 95% CI: 1.10–1.58). Similarly, ln(NLR) > 0.65 correlated positively with OAB (OR = 1.40; 95% CI: 1.16–1.71). Subgroup analyses revealed significant differences in alcohol use subgroups for ln(SII) ≤ 6.13 and ln(NLR) ≤ 0.65 (P for interaction < 0.05).Conclusions: SII and NLR may serve as biomarkers for assessing OAB risk.


  • Open Access

    Association between atherogenic index of plasma and incident aortic disease: a population-based prospective analysis

    by Cuihong Tian, Xiao Wang, Liang Tao, Wanyi Wei, Xuan Zhang, Haoxian Tang, Yequn Chen, Xuerui Tan

    Objective: To clarify whether atherogenic index of plasma (AIP), a comprehensive indicator reflecting both the protective and atherogenic effects of lipoproteins on cardiometabolic health, is associated with increased risk of aortic disease. Design: Large-scale, population-based, observational, prospective cohort study. Data sources: Health dataset from UK Biobank. Participants: A total of 17 530 participants, aged 40–70 years, were enrolled and completed the initial assessment visit before 2010. Participants with a history of aortic dissection (AD) or aortic aneurysm (AA), baseline connective tissue disease, missing triglyceride and high-density lipoprotein cholesterol values, fasting time less than 8 hours or those lost to follow-up were excluded. Main outcome measures: Aortic disease, a composite outcome comprising AD and AA. Results: During a median follow-up period of 15.1 years, 164 aortic disease cases, including 14 AD and 155 AA cases, were documented. A linear trend between AIP and the risk of incident aortic disease was confirmed (p for non-linear=0.134). The multivariable-adjusted incident risk of aortic disease gradually increased with elevated AIP tertiles (adjusted HR (aHR) 1.0 (reference) in tertile 1, aHR 1.48 (95% CI 0.91 to 2.41) in tertile 2, aHR 2.04 (95% CI 1.26 to 3.29) in tertile 3), following an adjustment for age, sex, smoking status, drinking status, body mass index, hypertension, low-density lipoprotein cholesterol and glycated haemoglobin. Specifically, participants in the highest AIP tertile had the highest incident risk of AA, with an aHR of 2.47 (95% CI 1.47 to 4.16). Conclusions: AIP is significantly associated with a higher risk of incident aortic disease, indicating that AIP is an effective risk assessment method for aortic disease, especially for AA.


  • Open Access

    Sex differences in the association between Life’s Essential 8 and serum anti-aging Klotho protein levels: a cross-sectional analysis in middle-aged to older adults

    by Jing Zeng, Tingting Zhang, Yan Yang, Jinjing Wang, Xiaojing Fan, Qiaomin Wang, Xuan Wang, Haoxian Tang, Yi Fang

    Background: This study explores the association between cardiovascular health metrics (Life’s Essential 8, LE8) and serum anti-aging Klotho protein levels among American adults aged 40–79, with a focus on sex-specific differences.Methods: Utilizing data from the 2007–2016 National Health and Nutrition Examination Survey (NHANES), we applied weighted multivariable regression analyses, restricted cubic spline (RCS) modeling, and subgroup analyses to investigate the association between Life’s Essential 8 (LE8) scores—including Health Behaviors and Health Factors scores—and serum Klotho concentrations, with a focus on gender differences.Results: Our study encompassed 9,534 participants, including 4,946 females and 4,588 males. Weighted multivariable regression analyses revealed that only females exhibited a positive association between Life’s Essential 8 (LE8) scores and serum Klotho protein levels. Specifically, a 10-point increase in LE8 scores resulted in an elevation of Klotho levels by 17.61 pg/mL (95% CI: 9.53–25.69). Similarly, a 10-point increase in Health Behaviors scores increased Klotho levels by 5.7 pg/mL (95% CI: 0.14–11.26), and a 10-point increase in Health Factors scores was associated with a rise in Klotho levels by 14.6 pg/mL (95% CI: 7.70–21.51). Sensitivity analyses showed a significant positive trend in Klotho levels correlating with improvements in cardiovascular health (CVH) levels among females (β = 72.9, 95% CI: 35.91–109.88; p for trend <0.001), consistent across both Health Behaviors and Health Factors scores. No similar trends were noted in males. In females, the dose-response relationship between LE8 scores and Health Factors scores displayed nonlinear patterns, whereas Health Behaviors scores showed linear patterns. Optimal threshold was identified at 65 for LE8 score. These results were consistent across various demographic and health statuses, emphasizing the sex-specific influence of LE8 scores on serum Klotho levels. This study underscores the importance of considering gender differences in cardiovascular health and its impact on anti-aging protein levels.Conclusion: In the present study, LE8 scores and its sub-scales were positively related to serum Klotho level in middle-aged and elderly women. This study provides new evidence of sex differences in the association between LE8 scores and serum anti-aging Klotho protein levels.


  • Open Access

    Effects of dietary live microbes intake on a newly proposed classification system for steatotic liver disease

    by Zhikun Dai, Zihong Bao, Hanyuan Lin, Qinglong Yang, Jingtao Huang, Xuan Zhang, Nan Luo, Haoxian Tang, Xiaohui Zhou

    Steatotic liver disease (SLD) is a common chronic liver disease without effective therapeutic options. Some studies suggest potential health benefits of dietary live microbes. This study aims to investigate the association between dietary live microbes intake and metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic alcohol-related liver disease (MetALD) / alcoholic liver disease (ALD) in adults. Data from the National Health and Nutrition Examination Survey 1999–2018 were analyzed. MASLD was defined according to the latest Delphi Consensus standard. Participants were grouped based on estimated dietary live microbe intake: low (< 104 CFU/g), moderate (104–107 CFU/g), and high (> 107 CFU/g). Multivariable logistic regression analysis was employed to assess the impact of dietary live microbes on MASLD/MetALD/ALD, along with further investigations into non-dietary probiotic/prebiotic relationships. Participants had a weighted mean age of 47.05 years (SE, 0.24) and 50.59% were female. MASLD proportions differ among low (21.76%), moderate (22.24%), and high (18.96%) microbe groups. Similarly, for MetALD, proportions are 7.75%, 6.95%, and 6.44%, and for ALD, 5.42%, 3.59%, and 2.97% in respective groups. The high dietary live microbe intake group was associated with a 16% lower risk of MASLD compared to those in the low intake group (trend test, P = 0.02), while the risk of ALD was reduced by 25% in the moderate intake group. A lack of association was identified between non-dietary prebiotic/probiotic and MASLD/MetALD/ALD. Our study suggests that a relatively high intake of live microbes diets in adults is associated with a lower risk of SLD.


  • Top Cited Papers

    Association of the newly proposed dietary index for gut microbiota and depression: the mediation effect of phenotypic age and body mass index

    by Xuan Zhang, Qinglong Yang, Jingtao Huang, Hanyuan Lin, Nan Luo, Haoxian Tang

    Background Gut microbiota and depression have garnered attention. The dietary index for gut microbiota (DI-GM) is a newly proposed index that reflects the diversity of gut microbiota, yet its association with depression remains unstudied. Methods Data from the National Health and Nutrition Examination Survey were analyzed. Depression was assessed using Patient Health Questionnaire (PHQ-9). Dietary recall data were used to calculate the DI-GM (including components beneficial and unfavorable to gut microbiota). Multivariable weighted logistic and linear regression were employed to investigate the association of DI-GM with depression and total PHQ-9 score. The potential mediating role of phenotypic age and body mass index (BMI) was explored. Secondary analyses included subgroup analyses, restricted cubic spline (RCS), and multiple imputation. Results A higher DI-GM and beneficial gut microbiota score were associated with a lower prevalence of depression (DI-GM: OR = 0.94, 95% CI = 0.89, 0.99; beneficial gut microbiota score: OR = 0.88, 95% CI = 0.82, 0.94) and lower total PHQ-9 score (DI-GM: β=-0.09, 95% CI=-0.14, -0.04; beneficial gut microbiota: β=-0.15, 95% CI=-0.21, -0.08). RCS indicated a non-linear relationship between DI-GM and depression. A significant mediating effect of phenotypic age (proportion of mediation: 19.81%, 95% CI: 12.86–63.00%) and BMI (proportion of mediation: 16.49%, 95% CI: 12.87–62.00%) was observed. Conclusions The newly proposed DI-GM was negatively associated with the prevalence of depression and total PHQ-9 score. Mediation analyses demonstrated a significant mediating effect of phenotypic age and BMI.


  • Association between flavonoid intake and rheumatoid arthritis among US adults

    by Yan Chen, Haoxian Tang, Nan Luo, Xiaoqing Liang, Penchao Yang, Xuan Zhang, Jingtao Huang, Qinglong Yang, Shuxin Huang, Ling Lin